C3orf62 and non-small cell lung carcinoma: Furthermore, we developed nomogram survival models by integrating clinical factors without (Fig. 3B) and with (Fig. 3C) circulating MAPS to predict the 1-, 3- and 5 year OS probability of NSCLC patients.